AVELOS THERAPEUTICS
LIVE

Serial Number

97439188

Owner

Avelos Therapeutics, Inc.

Attorney

Colleen Flynn Goss

Filing Date

Jun 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AVELOS THERAPEUTICS Trademark

Serial Number: 97439188

AVELOS THERAPEUTICS is a trademark filed by Avelos Therapeutics, Inc. on June 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Avelos Therapeutics, Inc.

325, Magokjungang 8-ro 7-gil
Gangseo-gu, Seoul 07794 , KR

Entity Type: 03

Trademark Details

Filing Date

June 1, 2022

Registration Date

Not Registered

Published for Opposition

June 23, 2026

Goods & Services

Pharmaceutical preparations and substances, for use in the field of oncology, central nervous system, immunology, and metabolic disease for the prevention and treatment of diseases of the central nervous system, immunological diseases, and metabolic diseases for medical purposes; anti-cancer preparations; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; biopharmaceuticals, namely, pharmaceutical products for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; compounds, namely, chemical preparations for medical purposes for treating cancer; biological preparations for the treatment of cancer; diagnostic preparations for medical purposes; biological preparations for the treatment of cancer for medical purposes

Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to scientific research in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; research and development of technology in the field of biotechnology; pharmaceutical research of biologics

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
May 22, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2026 CNEA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 11, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 10, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 9, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 6, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 5, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 5, 2024 GNSL
SUSPENSION LETTER WRITTEN
Nov 5, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2024 CRFA
ASSIGNED TO LIE
Oct 8, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 20, 2024 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 15, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 15, 2024 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 20, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 20, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 20, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 22, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 22, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 22, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2022 NWOS
NEW APPLICATION ENTERED
Jun 4, 2022 NWAP